The Esophagus. Группа авторов

Hepatol 2004; 2:340–3.

      43 44 Kessing BF, Govaert F, Masclee AA, et al. Impedance measurements and high‐resolution manometry help to better define rumination episodes. Scand J Gastroenterol 2011; 46:1310–5.

      44 45 Tucker E, Knowles K, Wright J et al. Rumination variations: aetiology and classification of abnormal behavioural responses to digestive symptoms based on high‐resolution manometry studies. Aliment Pharmacol Therap 2013; 37:263–74.

      45 46 Rommel N, Tack J, Arts J, et al. Rumination or belching‐regurgitation? Differential diagnosis using oesophageal impedance‐manometry. Neurogastroenterol Motil 2010; 22:104.

      46 47 Halland M, Parthasarathy G, Bharucha AE, et al. Diaphragmatic breathing for rumination syndrome: efficacy and mechanisms of action. Neurogastroenterol Motil 2016; 28:384–91.

      47 48 Kessing BF, Bredenoord AJ, Smout AJJ. Objective manometric criteria for the rumination syndrome. Am J Gastroenterol 2014; 109:52–9.

      48 49 Heard R, Castell J, Castell DO, Pohl D. Characterization of patients with low baseline impedance on multichannel intraluminal impedance‐pH reflux testing. J Clin Gastroenterol 2012; 46(7):e55–e57. doi:10.1097/MCG.0b013e318247c319.

      49 50 Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110:1982–96.

      50 51 Barlow WJ, Orlando RC. Th e pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005; 128:771–8.

      51 52 Tobey NA, Argote CM, Vanegas XC, et al. Electrical parameters and ion species for active transport in human esophageal stratified squamous epithelium and Barrett's specialized columnar epithelium. Am J Physio Gastrointest Liver Physiol 2007; 293:70.

      52 53 Orlando RC, Bryson JC, Powell DW. Mechanisms of H+ injury in rabbit esophageal epithelium. Am J Physiol 1984; 246:24.

      53 54 Tobey NA, Carson JL, Alkiek RA, et al. Dilated intercellular spaces: a morpho‐logical feature of acid reflux–damaged human esophageal epithelium. Gastroenterology 1996; 111:1200–5.

      54 55 Caviglia R, Ribolsi M, Gentile M, et al. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non‐erosive gastro‐oesophageal reflux disease. Aliment Pharmacol Therap 2007; 25:629–36.

      55 56 Orlando LA, Orlando RC. Dilated intercellular spaces as a marker of GERD. Curr Gastroenterol Rep 2009; 11:190–4.

      56 57 Kandulski A, Weigt J, Caro C, et al. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn. Clin Gastroenterol Hepatol 2015; 13:1075–81.

      57 58 Kessing BF, Bredenoord AJ, Weijenborg PW, et al. Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol 2011; 106:2093–7.

      58 59 Martinucci I, de Bortoli N, Savarino E, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil 2014; 26:546–55.

      59 60 de Bortoli N, Martinucci I, Savarino E, et al. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. Clin Gastroenterol Hepatol 2015; 13:1082–8.

      60 61 Waśko‐Czopnik D, Błoński W, Paradowski L. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus. Adv Med Sci 2007; 52:196–8.

      61 62 Hemmink GJ, Alvarez Herrero L, Bogte A, et al. Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation. Eur J Gastroenterol Hepatol 2013; 25:1024–32.

      62 63 Ravi K, Katzka DA. Esophageal impedance monitoring: clinical pearls and pitfalls. Am J Gastroenterol. 2016; 111(9):1245–1256. doi:10.1038/ajg.2016.256.

      63 64 Fass R, Hell R, Sampliner RE, et al. Effect of ambulatory 24‐hour esophageal pH monitoring on reflux‐provoking activities. Dig Dis Sci 1999; 44(11):2263–2269. doi:10.1023/a:1026608804938.

      64 65 Pandolfino JE, Schreiner MA, Lee TJ, Zhang Q, Boniquit C, Kahrilas PJ. Comparison of the Bravo wireless and Digitrapper catheter‐based pH monitoring systems for measuring esophageal acid exposure. Am J Gastroenterol 2005; 100(7):1466–1476. doi:10.1111/j.1572‐0241.2005.41719.x.

      65 66 Patel DA, Higginbotham T, Slaughter JC, et al. Development and validation of a mucosal impedance contour analysis system to distinguish esophageal disorders. Gastroenterology 2019; 156(6):1617–1626.e1. doi:10.1053/j.gastro.2019.01.253.

      66 67 Katzka DA, Tadi R, Smyrk TC, et al. Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014; 12(11):1824–9.e1. doi:10.1016/j.cgh.2014.02.039.

      67 68 Katzka DA, Ravi K, Geno DM, et al. Endoscopic mucosal impedance measurements correlate with eosinophilia and dilation of intercellular spaces in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2015; 13(7):1242–1248.e1. doi:10.1016/j.cgh.2014.12.032.

      68 69 Lowry MA, Vaezi M, Correa H, Higginbotham T, Slaughter JC, Acra S. An innovative mucosal impedance device differentiates active eosinophilic esophagitis from inactive disease, NERD and controls. Gastrointestinal Endoscopy 2016 May 1; 83(5):AB166.

      69 70 Yuksel ES, Higginbotham T, Slaughter JC, et al. Use of direct, endoscopic‐guided measurements of mucosal impedance in diagnosis of gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2012; 10(10):1110–1116. doi:10.1016/j.cgh.2012.05.018.

      70 71 Ates F, Yuksel ES, Higginbotham T, et al. Mucosal impedance discriminates GERD from non‐GERD conditions. Gastroenterology 2015; 148:334–43.

      71 72 van Rhijn BD, Verheij J, van den Bergh Weerman MA, et al. Histological response to fluticasone propionate in patients with eosinophilic esophagitis is associated with improved functional esophageal mucosal integrity. Am J Gastroenterol 2015; 110:1289–97.

      72 73 Katzka DA, Ravi K, Geno DM, et al. Endoscopic mucosal impedance measurements correlate with eosinophilia and dilation of intercellular spaces in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2015; 13:1242–12480.

      73 74 Zheng E, Gideon RM, Sloan J, Katz PO. Esophagogastric junction outflow obstruction is often associated with coexistent abnormal esophageal body motility and abnormal bolus transit. Dis Esophagus. 2017; 30(10):1–4. doi:10.1093/dote/dox066.

      74 75 Jain A, Baker JR, Rubenstein JH, Chen JW. Bolus clearance in esophagogastric junction outflow obstruction is associated with strength of peristalsis. Neurogastroenterol Motil. 2017; 29(9):10.1111/nmo.13093. doi:10.1111/nmo.13093.

      75 76 Song BG, Min YW, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ. Combined multichannel intraluminal impedance and high‐resolution manometry improves detection of clinically relevant esophagogastric junction outflow obstruction. J Neurogastroenterol Motil 2019; 25(1):75–81. https://doi.org/10.5056/jnm18148.

      76 77 Beveridge C, Lynch K. Diagnosis and management of esophagogastric junction outflow obstruction. J. Gastroenterol Hepatol 2020; 16(3):131.